Gwendoline Chimhini1, Ioana Diana Olaru1,2, Felicity Fitzgerald3, Mutsawashe Chisenga2, Cecilia Ferreyra4, Nada Malou4, Jeremie Piton4, Simbarashe Chimhuya1, Shunmay Yeung1,5, Surjo De6, Hilda A Mujuru1, Katharina Kranzer7,2,8. 1. From the Child and Adolescent Health Unit, Faculty of Medicine and Health Sciences, University of Zimbabwe. 2. Biomedical Research and Training Institute, Harare, Zimbabwe. 3. Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom. 4. FIND (Foundation for Innovative New Diagnostics), Geneva, Switzerland. 5. Department of Paediatric Infectious Disease, St Mary's Imperial College Hospital. 6. Department of Clinical Microbiology, University College London Hospitals NHS Foundation Trust, London, United Kingdom. 7. Clinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom. 8. Division of Infectious and Tropical Medicine, Medical Centre of the University of Munich, Munich, Germany.
Abstract
BACKGROUND: Neonatal sepsis accounts for a large proportion of neonatal deaths in sub-Saharan Africa. The lack of access to diagnostic testing and excessively long turnaround times to result contributes to delays in sepsis identification and initiation of appropriate treatment. This study aims to evaluate the novel InTrays COLOREX Screen and extended-spectrum beta-lactamase for rapid identification of bacterial pathogens causing sepsis and detection of resistance. METHODS: Neonates with suspected sepsis admitted to the Harare Central Hospital were prospectively enrolled. One blood culture was collected and incubated using the BacT/ALERT automated system. Positive blood cultures with potential pathogens identified by Gram stain were inoculated on the InTray COLOREX Screen and extended-spectrum beta-lactamase culture plates. RESULTS: A total of 216 neonates with suspected sepsis were recruited. Pathogens were isolated from blood cultures in 56 (25.9%) neonates of which 54 were Klebsiella pneumoniae. All K. pneumoniae were resistant to ceftriaxone and 53 (98%) were resistant to gentamicin. Sensitivity and specificity for ceftriaxone-resistant K. pneumoniae detection using InTrays were 100%. InTrays results were interpretable as early as 5-10 hours (median 7 hours, interquartile range 7-7) post blood culture positivity enabling rapid identification and notification of result and leading to a 60% reduction in time to result from blood culture collection. CONCLUSIONS: This study shows that the implementation of a novel culture method was feasible and reduced turnaround times for results by 60% compared with standard microbiologic techniques. An impact on patient outcomes and cost-effectiveness of this method needs to be demonstrated.
BACKGROUND: Neonatal sepsis accounts for a large proportion of neonatal deaths in sub-Saharan Africa. The lack of access to diagnostic testing and excessively long turnaround times to result contributes to delays in sepsis identification and initiation of appropriate treatment. This study aims to evaluate the novel InTrays COLOREX Screen and extended-spectrum beta-lactamase for rapid identification of bacterial pathogens causing sepsis and detection of resistance. METHODS: Neonates with suspected sepsis admitted to the Harare Central Hospital were prospectively enrolled. One blood culture was collected and incubated using the BacT/ALERT automated system. Positive blood cultures with potential pathogens identified by Gram stain were inoculated on the InTray COLOREX Screen and extended-spectrum beta-lactamase culture plates. RESULTS: A total of 216 neonates with suspected sepsis were recruited. Pathogens were isolated from blood cultures in 56 (25.9%) neonates of which 54 were Klebsiella pneumoniae. All K. pneumoniae were resistant to ceftriaxone and 53 (98%) were resistant to gentamicin. Sensitivity and specificity for ceftriaxone-resistant K. pneumoniae detection using InTrays were 100%. InTrays results were interpretable as early as 5-10 hours (median 7 hours, interquartile range 7-7) post blood culture positivity enabling rapid identification and notification of result and leading to a 60% reduction in time to result from blood culture collection. CONCLUSIONS: This study shows that the implementation of a novel culture method was feasible and reduced turnaround times for results by 60% compared with standard microbiologic techniques. An impact on patient outcomes and cost-effectiveness of this method needs to be demonstrated.
Authors: Shahin Sayed; William Cherniak; Mark Lawler; Soo Yong Tan; Wafaa El Sadr; Nicholas Wolf; Shannon Silkensen; Nathan Brand; Lai Meng Looi; Sanjay A Pai; Michael L Wilson; Danny Milner; John Flanigan; Kenneth A Fleming Journal: Lancet Date: 2018-03-15 Impact factor: 79.321
Authors: Uduak Okomo; Edem N K Akpalu; Kirsty Le Doare; Anna Roca; Simon Cousens; Alexander Jarde; Mike Sharland; Beate Kampmann; Joy E Lawn Journal: Lancet Infect Dis Date: 2019-09-12 Impact factor: 25.071
Authors: Coosje J Tuijn; Elizabeth Msoka; Declare L Mushi; Marion Sumari-de Boer; Jaffu Chilongola; Ankie van den Broek Journal: Afr J Lab Med Date: 2014-07-23
Authors: Sien Ombelet; Barbara Barbé; Dissou Affolabi; Jean-Baptiste Ronat; Palpouguini Lompo; Octavie Lunguya; Jan Jacobs; Liselotte Hardy Journal: Front Med (Lausanne) Date: 2019-06-18
Authors: Anna Åkerlund; Emma Jonasson; Erika Matuschek; Lena Serrander; Martin Sundqvist; Gunnar Kahlmeter Journal: J Antimicrob Chemother Date: 2020-11-01 Impact factor: 5.790
Authors: G Chimhini; S Chimhuya; L Madzudzo; M Heys; C Crehan; V Robertson; R A Ferrand; B Sado; M Sharland; A S Walker; N Klein; F C Fitzgerald Journal: Infect Prev Pract Date: 2020-02-19